What is CIDP (Chronic Inflammatory Demyelinating Polyneuropathy)?

Chronic inflammatory demyelinating polyneuropathy, often called CIDP, is a rare condition that affects the nerves outside the brain and spinal cord. It happens when the body’s immune system, which normally fights infections, mistakenly damages a protective coating around the nerves called myelin. When this coating is damaged, the nerves cannot send signals through the body properly. This can lead to weakness, numbness, tingling, and changes in reflexes that build up slowly over weeks or months. CIDP can affect adults of any age, though it is most often diagnosed in middle adulthood. The sections that follow explain the symptoms, possible causes, how the condition is diagnosed, and how it is treated.

What does CIDP actually mean?

The full name of the condition can be broken into four parts, each describing something about the disease.

• Chronic: the symptoms last a long time, usually building up over at least eight weeks.
• Inflammatory: inflammation plays a role in the disease.
• Demyelinating: damage is centered on myelin, the fatty coating that wraps around nerves and helps them carry signals.
• Polyneuropathy: many nerves throughout the body are affected, not just one.

Some doctors use a slightly longer name, chronic inflammatory demyelinating polyradiculoneuropathy, to highlight that the nerve roots near the spinal cord are also involved. Both names describe the same condition.

How CIDP affects the nerves

The nerves outside the brain and spinal cord work much like electrical wires. They carry signals back and forth between the brain and the rest of the body. Each nerve is wrapped in a protective coating called myelin, which helps signals travel quickly and clearly. When myelin is damaged, the signals slow down, become scrambled, or fail to reach where they need to go.

In CIDP, the immune system, which usually protects the body from infection, mistakenly attacks myelin instead. This damages the protective coating, though the nerves themselves often remain in place during the early stages of the disease. This is why CIDP often causes:

• Muscle weakness in the parts of the body controlled by affected nerves.
• Numbness, tingling, or other changes in sensation.
• Reduced or missing reflexes, since the signals are not reaching their targets the way they should.

CIDP affects the nerves outside the brain and spinal cord. The brain itself is not directly involved, and CIDP does not cause memory loss or other changes in thinking.

How common is CIDP?

CIDP is a rare condition. Estimates suggest that about one to two people out of every 100,000 are newly diagnosed each year. Because the disease can last a long time, the total number of people living with CIDP at any given moment may be higher, possibly up to nine per 100,000 in some areas.

A few patterns about who CIDP affects:

• It can occur in adults of any age but is most often diagnosed in people in their 40s, 50s, or 60s.
• Men are diagnosed about twice as often as women.
• Children can develop CIDP, though it is much less common than in adults.
• CIDP is not contagious, and it is not passed directly from parent to child.

What are the symptoms of CIDP?

CIDP symptoms usually appear slowly, over weeks or months. They tend to affect both sides of the body in a similar way, which is one of the patterns doctors look for when making the diagnosis. The most commonly reported symptoms include:

• Progressive weakness in the legs, including difficulty climbing stairs, getting up from a chair, or walking distances that used to be easy.
• Numbness, tingling, or burning sensations in the hands and feet that may spread over time.
• Loss of balance and a sense of being unsteady, because the nerves are not sending clear signals about where the limbs are positioned.
• Difficulty with small movements that require coordination, such as buttoning a shirt, holding a pen, or turning a key.
• Fatigue, which many people describe as one of the most disruptive symptoms day to day.

The way CIDP unfolds is different from person to person. For some, symptoms steadily get worse over time. For others, symptoms improve for a while and then come back later. A smaller number of people experience a single episode that does not return after treatment. Across all of these patterns, the shared feature is that symptoms develop or worsen over a period of at least eight weeks. This timeline helps separate CIDP from a similar but faster-developing condition called Guillain-Barré syndrome.

In a smaller number of cases, CIDP can affect the nerves that control facial movement, swallowing, or breathing. These symptoms need urgent medical attention. Difficulty swallowing, slurred speech, or shortness of breath should be evaluated right away.

What causes CIDP?

Doctors and researchers do not fully understand what causes CIDP. The condition is considered autoimmune, which means the immune system mistakenly attacks the body’s own tissue instead of attacking something like a germ. In most cases, the specific reason this misdirected response begins is not known.

Research has identified a few patterns:

• CIDP sometimes appears after a viral or bacterial infection. The immune system’s response to the infection may, in some people, become misdirected against the nerves’ protective coating.
• It can occur alongside other health conditions, such as diabetes, lupus, HIV, hepatitis, and certain blood disorders.
• Some research suggests there may be a small genetic component, but no specific gene has been identified as a cause. Most people with CIDP do not have a family history of the condition.

Because a specific cause cannot be pinpointed in most cases, treatment focuses on calming the immune response rather than addressing what triggered it.

How is CIDP diagnosed?

There is no single test that confirms CIDP. Doctors make the diagnosis by putting several pieces of information together:

• Medical history and physical exam, including how symptoms started, how they have changed, and tests of muscle strength, reflexes, and sensation.
• Nerve tests, such as nerve conduction studies and electromyography (EMG). These measure how well the nerves carry electrical signals. Slowed signals are a common sign of the kind of nerve damage seen in CIDP.
• Spinal fluid test (lumbar puncture or spinal tap), in which a small amount of fluid is taken from around the lower spine. A specific pattern in the fluid, with higher than usual protein but a normal cell count, is often seen in CIDP.
• Blood tests, which help rule out other causes of nerve problems, such as vitamin deficiency, thyroid issues, or certain infections that can cause similar symptoms.
• MRI scan or, in rare cases, a small sample of nerve tissue (nerve biopsy), used when the diagnosis is not clear after other testing.

Getting to a CIDP diagnosis often takes time. Studies have shown that many patients are first diagnosed with another condition, and that the time from when symptoms begin to when CIDP is confirmed can be several months on average.

Getting diagnosed early matters because untreated CIDP can damage the nerves themselves, not just the protective coating around them. The protective coating has some ability to heal, but the nerves underneath usually cannot fully recover once they are damaged. Starting treatment early may help prevent damage that cannot be undone later.

Seeing a neurologist who has experience treating CIDP can be helpful, especially when the symptoms are unusual or the diagnosis is not yet clear after early testing.

How is CIDP treated?

Treatment for CIDP aims to calm the immune system’s mistaken attack on the nerves, slow further damage, and help the nerves recover. Several treatment options are available. The right choice depends on individual factors such as how severe the symptoms are, the person’s overall health, and how they have responded to past treatments.

The most commonly used treatments include:

• Intravenous immunoglobulin (IVIG): a treatment made from antibodies donated by other people. It is given through an IV, usually on a regular schedule. IVIG is often the first treatment tried.
• Subcutaneous immunoglobulin (SCIg): a similar antibody-based treatment, but given as an injection under the skin instead of through an IV. It is sometimes used for ongoing treatment once symptoms are under control.
• Plasma exchange (plasmapheresis): a procedure that filters the blood to remove the antibodies thought to be causing the nerve damage. It is usually used during a flare-up or when other treatments have not worked well.
• Steroid medications: such as prednisone, which calm the immune system overall. These can work well for some people but can have significant side effects when used for a long time, so they need to be managed carefully.
• Other medications that reduce immune system activity: these may be added when the first-choice treatments are not enough to keep the disease under control.

These treatments are used in both adults and children with CIDP, though each treatment plan is tailored to the individual. How well someone responds varies, and it is common for the treatment plan to be adjusted over time.

Researchers continue to study new ways to treat CIDP. Clinical trials are ongoing to better understand potential treatment options and how they may help people living with the condition. Those interested in learning more can discuss available research with their healthcare provider.

What does life with CIDP look like?

With the right medical care, many people with CIDP continue to work, care for their families, enjoy hobbies, and travel. Several kinds of support are often part of long-term care:

• Physical therapy to help maintain muscle strength, balance, and movement.
• Occupational therapy to find easier ways to do everyday tasks and identify helpful tools.
• Strategies to manage fatigue, which many people describe as one of the most persistent symptoms of the disease.
• Mental health support, since adjusting to a long-term health condition can be emotionally difficult.

How well people do with CIDP varies a lot from one person to the next. A complete return to how things were before the diagnosis is not common. Many people continue to have some mild weakness, changes in sensation, or fatigue, even when CIDP is otherwise well controlled. Talking through realistic expectations with a doctor is an important part of long-term care.

What is the long-term outlook?

Long-term outcomes with CIDP differ widely from one person to another. Some people experience long periods without symptoms after initial treatment. Others manage CIDP as a long-term condition that requires ongoing care. Available evidence suggests that, overall, life expectancy with CIDP is similar to that of the general population.

The outlook depends on several things, such as the pattern of the disease, how early treatment began, and how the body responds to treatment. Predicting how things will go for any one person is difficult, and that conversation is best had with a neurologist who knows the full medical history.

Studies have shown that, without treatment, a meaningful number of people with CIDP eventually develop serious difficulties with movement, including, in some cases, needing a wheelchair. Earlier diagnosis and timely treatment can reduce the chances of this happening, which is one of the main reasons not to delay seeking medical care when CIDP is suspected.

Questions patients may wish to discuss with a doctor

Topics often raised during ongoing care for CIDP include:

• The specific type of CIDP that has been diagnosed and what that means for treatment.
• Which treatment is being recommended first and the reasoning behind that choice.
• How long it usually takes to see results from treatment and how progress will be measured.
• Side effects to watch for and signs that should prompt a call to the doctor.
• Whether seeing a neurologist with experience in CIDP would be helpful.
• Information about ongoing research that may be relevant.

Frequently asked questions

What does CIDP stand for?

CIDP stands for chronic inflammatory demyelinating polyneuropathy. Some doctors use a slightly longer name, chronic inflammatory demyelinating polyradiculoneuropathy, to highlight that the nerve roots near the spinal cord are also involved. Both names describe the same condition.

What are the early warning signs of CIDP?

Early signs of CIDP usually develop slowly, over weeks or months. Common signs include gradual weakness in the legs, such as difficulty climbing stairs or getting up from a chair, along with numbness or tingling in the hands and feet. Some people notice loss of balance, fatigue, or difficulty with small tasks like buttoning clothing. Symptoms typically affect both sides of the body in a similar way. Because these signs can resemble other conditions, medical evaluation is important when they persist or get worse over time.

Is CIDP disease curable?

CIDP is not generally considered curable in the strict sense, but it is treatable. Treatment can lead to meaningful improvement for many people, and some experience long periods without symptoms. Others manage CIDP as a long-term condition that requires ongoing care. Available evidence suggests that response to treatment varies between individuals, and outcomes depend on factors such as how early treatment was started and how the body responds. Working with a neurologist experienced in CIDP can help guide the most appropriate approach for each person.

Is CIDP the same as multiple sclerosis (MS)?

No. Although both involve damage to a protective coating around nerves, they affect different parts of the nervous system. MS affects the central nervous system, which includes the brain and spinal cord. CIDP affects the nerves outside of those areas. The two conditions have different symptoms, treatments, and long-term courses, even though they can sound similar.

Does CIDP get worse over time?

The course of CIDP varies from person to person. Some people experience symptoms that gradually get worse over time. Others have symptoms that improve for stretches and then flare up again, while a smaller number have a single episode that does not return after treatment. Without treatment, CIDP may lead to progressive nerve damage and increasing disability over time. With treatment, many people stabilize or improve, though some continue to have mild symptoms even when the condition is otherwise well controlled. Early diagnosis and ongoing care may help reduce the likelihood of worsening over time.

Summary

CIDP is a rare condition in which the immune system damages the protective coating around the nerves outside the brain and spinal cord. Symptoms tend to develop slowly and may include increasing weakness, numbness or tingling, changes in reflexes, and fatigue. Doctors diagnose CIDP by combining a medical history, a physical exam, nerve tests, and other lab work. Several treatment options are available, including antibody-based therapies, blood-cleaning procedures, and steroid medications, and how well each person responds varies.

Seeing a neurologist with experience in CIDP can be especially helpful during the diagnostic process and when planning treatment. Researchers continue to study new ways to treat the condition and improve existing approaches.